Accession Number: | 0001209191-21-005249 |
Date: | 2021-01-21 |
Issuer: | TRAVERE THERAPEUTICS, INC. (TVTX) |
Original Submission Date: |
DUBE ERIC M
C/O TRAVERE THERAPEUTICS, INC.
3611 VALLEY CENTRE DR., SUITE 300
SAN DIEGO, CA 92130
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-01-21 | A | 57,260 | a | $0.00 | 145,079 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 26.88 | 2021-01-21 | deemed execution date | A | 212,600 (a) | 2031-01-20 | common stock 212,600 | $26.88 | 212,600 | direct |
ID | footnote |
---|---|
f1 | acquisition of restricted stock units pursuant to the issuer's equity incentive plan that are scheduled to vest over four years. |
f2 | one-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of the date of grant, and the remaining shares vest in 36 equal monthly installments thereafter. |